XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Class A Common Stock
Class A Common Stock
Additional Paid-in- Capital
Retained Earnings
Treasury Stock, at Cost
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2020 $ 430 $ 5 $ 5,851 $ 9,206 $ (14,497) $ (135)
Beginning balance (in shares) at Dec. 31, 2020   324,400,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,099     1,099    
Other comprehensive income (loss) (207)         (207)
Stock-based compensation plans (in shares)   1,900,000        
Stock-based compensation plans 92   41   51  
Ending balance at Dec. 31, 2021 1,414 $ 5 5,892 10,305 (14,446) (342)
Ending balance (in shares) at Dec. 31, 2021   326,300,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,358     2,358    
Other comprehensive income (loss) (387)         (387)
Dividends (321)     (321)    
Stock-based compensation plans (in shares)   1,100,000        
Stock-based compensation plans 104   73   31  
Purchase of treasury stock (2,600)       (2,600)  
Purchase of treasury stock (in shares)   (16,800,000)        
Ending balance at Dec. 31, 2022 568 $ 5 5,965 12,342 (17,015) (729)
Ending balance (in shares) at Dec. 31, 2022   310,600,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 3,083     3,083    
Other comprehensive income (loss) 82         82
Dividends (587)     (587)    
Stock-based compensation plans (in shares)   1,400,000        
Stock-based compensation plans 126   86   40  
Purchase of treasury stock (3,954)       (3,954)  
Purchase of treasury stock (in shares)   (21,500,000)        
Ending balance at Dec. 31, 2023 $ (682) $ 5 $ 6,051 $ 14,838 $ (20,929) $ (647)
Ending balance (in shares) at Dec. 31, 2023 290,539,975 290,500,000 [1]        
[1] Our restated certificate of incorporation authorizes 800,000,000 shares of our common stock, with a par value of $0.01 per share and 10,000,000 shares of preferred stock, without par value. At year-end 2023, we had 290,539,975 of these authorized shares of our common stock and no preferred stock outstanding.